Psychiatry and Neurology, Neurology · Roseville, MN
NPI
1902092091
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2720 Fairview Ave N Ste 100
Roseville, MN, 55113
Phone (651) 241-2905
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
331 services
Medicare patients, 2024
185
Average age 62
Drug cost, 2024
$1.6M
3,677 prescriptions
Company payments, 2025
$9,667
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kinshuk Sahaya was code 95720 (neurologic), 129 times for 83 patients. In total Kinshuk Sahaya billed 331 services in 24 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 129 | 83 | $154.38 | $20K |
| 99213 Office E&M - Established | Office | 46 | 42 | $52.21 | $2,402 |
| 99214 Office E&M - Established | Office | 42 | 31 | $72.16 | $3,031 |
| 95718 Neurologic | Facility | 25 | 25 | $100.14 | $2,503 |
By year: 2022 $32K for 309 services; 2023 $41K for 399 services; 2024 $37K for 331 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kinshuk Sahaya prescribed most often to Medicare patients was Levetiracetam, with 483 prescriptions and refills. In total Kinshuk Sahaya wrote 3,677 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 483 | 700 | 68 | $20K |
| Lamotrigine Generic | 441 | 559 | 42 | $14K |
| Lacosamide Generic | 383 | 417 | 42 | $49K |
| Topiramate Generic | 288 | 315 | 18 | $11K |
| Clobazam Generic | 179 | 189 | 20 | $19K |
| Divalproex Sodium Er Divalproex Sodium | 168 | 182 | 15 | $6,841 |
| Xcopri Cenobamate | 146 | 158 | 16 | $205K |
| Briviact Brivaracetam | 144 | 145 | 18 | $326K |
| Oxcarbazepine Generic | 138 | 171 | 13 | $6,994 |
| Carbamazepine Er Carbamazepine | 136 | 166 | 12 | $10K |
| Zonisamide Generic | 128 | 159 | 16 | $4,106 |
| Pregabalin Generic | 124 | 147 | 14 | $2,868 |
| Levocarnitine Generic | 106 | 116 | 11 | $9,227 |
| Felbamate Generic | 104 | 131 | 12 | $39K |
| Epidiolex Cannabidiol (Cbd) | 88 | 97 | Under 11 | $578K |
Brand drugs: 538 claims; generic drugs: 3,104 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kinshuk Sahaya $9,667 ($9,667 in general payments such as food, travel and fees) from 2 companies. The largest payer was SK Life Science, Inc. with $9,590.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 13 | $9,590 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $77.16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.